ProfileGDS4718 / 202353_s_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 90% 87% 94% 91% 91% 94% 93% 90% 86% 91% 93% 88% 88% 91% 92% 89% 90% 85% 92% 82% 92% 90% 90% 90% 91% 91% 89% 85% 88% 93% 81% 93% 89% 89% 88% 92% 91% 89% 87% 95% 88% 92% 86% 80% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]9.2291490
GSM549102patient 115, normal, homogenized [OPG study]8.6938287
GSM549104patient 119, normal, homogenized [OPG study]9.9653494
GSM549108patient 138, normal, homogenized [OPG study]9.338391
GSM549119patient 077, normal, homogenized [OPG study]9.4692591
GSM549133patient 032, cancer, homogenized [OPG study]10.044894
GSM549139patient 042, cancer, homogenized [OPG study]9.6859193
GSM549099patient 107, normal, homogenized [OPG study]9.0690190
GSM549109patient 139, normal, homogenized [OPG study]8.6018886
GSM549110patient 046, normal, homogenized [OPG study]9.3797191
GSM549114patient 063, normal, homogenized [OPG study]9.9435993
GSM549122patient 082, normal, homogenized [OPG study]8.9402288
GSM549134patient 033, cancer, homogenized [OPG study]8.8788488
GSM549136patient 036, cancer, homogenized [OPG study]9.3544691
GSM549140patient 044, cancer, homogenized [OPG study]9.5767892
GSM549111patient 047, normal, homogenized [OPG study]9.0361689
GSM549113patient 057, normal, homogenized [OPG study]9.3002390
GSM549132patient 031, cancer, homogenized [OPG study]8.5013885
GSM549137patient 038, cancer, homogenized [OPG study]9.4299892
GSM549142patient 047, cancer, homogenized [OPG study]7.7992282
GSM549100patient 110, normal, homogenized [OPG study]9.4725392
GSM549107patient 135, normal, homogenized [OPG study]9.2835490
GSM549115patient 068, normal, homogenized [OPG study]9.3866290
GSM549116patient 072, normal, homogenized [OPG study]9.2872490
GSM549120patient 078, normal, homogenized [OPG study]9.4527791
GSM549131patient 030, cancer, homogenized [OPG study]9.3861291
GSM549118patient 074, normal, homogenized [OPG study]9.1096389
GSM549129patient 027, cancer, homogenized [OPG study]8.3967785
GSM549123patient 088, normal, homogenized [OPG study]8.9501588
GSM549124patient 006, cancer, homogenized [OPG study]9.6151493
GSM549126patient 015, cancer, homogenized [OPG study]8.0192781
GSM549128patient 025, cancer, homogenized [OPG study]9.7123893
GSM549103patient 117, normal, homogenized [OPG study]8.8633989
GSM549117patient 073, normal, homogenized [OPG study]9.2658389
GSM549138patient 041, cancer, homogenized [OPG study]8.9085588
GSM549141patient 045, cancer, homogenized [OPG study]9.6055392
GSM549130patient 028, cancer, homogenized [OPG study]9.2787191
GSM549101patient 111, normal, homogenized [OPG study]8.946789
GSM549105patient 128, normal, homogenized [OPG study]8.755587
GSM549106patient 134, normal, homogenized [OPG study]10.355595
GSM549112patient 048, normal, homogenized [OPG study]8.8717488
GSM549125patient 011, cancer, homogenized [OPG study]9.3859192
GSM549127patient 024, cancer, homogenized [OPG study]8.5631486
GSM549135patient 035, cancer, homogenized [OPG study]7.9337580